Joel Pekow
University of Chicago
H-index: 39
North America-United States
Top articles of Joel Pekow
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
P848 Risankizumab Effectiveness in Ustekinumab-naïve and Ustekinumab-experienced Patients with Crohn’s Disease-Real-world Data from a Large Tertiary Center | Journal of Crohn's and Colitis | A Zinger D Choi N Choi E Fear Z Fine | 2024/1/1 |
P465 Upadacitinib is effective and safe for the treatment of ulcerative colitis and Crohn’s disease: 1-year prospective real-world experience | Journal of Crohn's and Colitis | N Krugliak Cleveland NK Choi JA Klein EN Fear ZD Fine | 2024/1/1 |
Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium | Inflammatory Bowel Diseases | Andres J Yarur Ryan Ungaro Katherine Huang Wenfei Wang Priya Sasankan | 2024/3/26 |
Real world clinical effectiveness and safety of ozanimod in the treatment of ulcerative colitis: 1-year follow-up from a tertiary center | Digestive Diseases and Sciences | Nathaniel A Cohen David Choi Nicole Garcia Natalie K Choi Emma Picker | 2024/2 |
Yield of Serial Testing for Tuberculosis Exposure in Patients With Inflammatory Bowel Diseases: One Test is Not Enough | Clinical Gastroenterology and Hepatology | Sean L Lapp Meenakshi Bewtra James D Lewis Manreet Kaur Themistocles Dassopoulos | 2024/2/1 |
Patients with Acute Severe Ulcerative Colitis Treated with IV Cyclosporine Who Require Colectomy Within 3 Months of Discharge Have Lower Serum Cyclosporine Levels | Scott Friedberg Joshua M Steinberg Jeremy A Klein Natalie K Choi David Choi | 2024/1/15 | |
Comparison of the risk of Crohn’s disease postoperative recurrence between modified Rutgeerts score i2a and i2b categories: An individual patient data meta-analysis | Journal of Crohn's and Colitis | Pauline Rivière Joel Pekow Nassim Hammoudi Pauline Wils Peter De Cruz | 2023/2/1 |
Endo-histologic normalization is achievable with tofacitinib and is associated with improved clinical outcomes | Nathaniel A Cohen Joshua M Steinberg Alexa Silfen Cindy Traboulsi Tina G Rodriguez | 2023/4 | |
Pathways Related to Colon Inflammation Are Associated with Colorectal Carcinoma: A Transcriptome-and Methylome-Wide Study | Cancers | Muhammad G Kibriya Farzana Jasmine Joel Pekow Aaron Munoz Christopher Weber | 2023/5/26 |
Assessment of the current spatial-temporal variations of total dissolved solids on the surface waters of Kuala Perlis, Perlis | Journal of Academia | Aimie Rifhan Hashim Sharir Aizat Kamaruddin Jamil Tajam Faeiza Buyong Che-Zulkifli Che Ismail | 2023 |
Serum cytomegalovirus polymerase chain reaction test is a valuable negative predictor of infection in acute severe ulcerative colitis | Digestive Diseases and Sciences | Nathaniel A Cohen Maryam Zafer Namrata Setia Michael J Anderson Atsushi Sakuraba | 2023/3 |
Tu1784 UPADACITINIB IS EFFECTIVE AND SAFE FOR CROHN'S DISEASE: PROSPECTIVE REAL-WORLD EXPERIENCE | Gastroenterology | Scott Friedberg David Choi Thomas Hunold Natalie K Choi Nicole M Garcia | 2023/5/1 |
P800 Upadacitinib is effective and safe for Crohn’s Disease: prospective real-world experience | Journal of Crohn's and Colitis | S Friedberg D Choi T Hunold NK Choi NM Garcia | 2023/2/1 |
Tu1803 REAL WORLD EFFECTIVENESS AND SAFETY OF OZANIMOD: ONE-YEAR FOLLOW-UP FROM A LARGE TERTIARY CENTER | Gastroenterology | Nathaniel A Cohen David Choi Nicole M Garcia Natalie K Choi Emma A Picker | 2023/5/1 |
Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis | Therapeutic Advances in Gastroenterology | Omar K Jamil Dustin Shaw Zifeng Deng Nicholas Dinardi Natalie Fillman | 2023/9 |
P580 Upadacitinib is effective and safe for Ulcerative Colitis: prospective real-world experience | Journal of Crohn's and Colitis | S Friedberg D Choi T Hunold NK Choi NM Garcia | 2023/2/1 |
Tu1806 REAL-WORLD EFFECTIVENESS AND SAFETY OF UPADACITINIB IN ULCERATIVE COLITIS: A MULTICENTER STUDY | Gastroenterology | Anish Patel Amanda M Johnson Jeffrey Berinstein David Dulaney Marc Fenster | 2023/5/1 |
Upadacitinib is effective and safe in both ulcerative colitis and Crohn’s disease: prospective real-world experience | Clinical Gastroenterology and Hepatology | Scott Friedberg David Choi Thomas Hunold Natalie K Choi Nicole M Garcia | 2023/7/1 |
P562 Real world effectiveness and safety of ozanimod: One-year follow-up from a large tertiary center | Journal of Crohn's and Colitis | NA Cohen D Choi N Garcia N Choi E Picker | 2023/2/1 |
Tu1791 UPADACITINIB IS EFFECTIVE AND SAFE IN TOFACITINIB-EXPERIENCED PATIENTS WITH ULCERATIVE COLITIS: A PROSPECTIVE REAL-WORLD EXPERIENCE | Gastroenterology | Noa Cleveland Scott Friedberg David Choi Thomas Hunold Natalie K Choi | 2023/5/1 |
